NeuroMEDx
NeuroMEDx is developing innovative technologies for treating various neurological disorders such as Parkinson’s, Essential Tremor, Epilepsy, Obesity, Incontinence, and Migraine. The company holds multiple patents and aims to significantly impact disease treatment and reduce healthcare costs through its platform technology and mechanoelectric devices.
Industries
Nr. of Employees
small (1-50)
NeuroMEDx
Suite 301, 501 West Saint Germain St., Saint Cloud, MN 56301
Products
Mechanoelectric implantable devices (MEDs)
Implantable devices designed to be placed within targeted tissues to therapeutically apply localized mechanical stresses and strains to modify tissue physiological properties and function.
Mechanoelectric implantable devices (MEDs)
Implantable devices designed to be placed within targeted tissues to therapeutically apply localized mechanical stresses and strains to modify tissue physiological properties and function.
Expertise Areas
- Neuromodulation device development
- Implantation delivery systems and imaging-guided placement
- Preclinical evaluation of implantable therapeutics
- Device platform engineering for tissue modulation
Key Technologies
- Mechanoelectric implantable devices
- Imaging-guided implantation (MRI/CT)
- Minimally-invasive delivery systems
- Localized mechanical tissue modulation
News & Updates
Broad US patent granted to NeuroMEDx, covering its platform technology.
Broad US patent granted to NeuroMEDx, covering its platform technology.
Broad US patent granted to NeuroMEDx, covering its platform technology.
Broad US patent granted to NeuroMEDx, covering its platform technology.
Broad US patent granted to NeuroMEDx, covering its platform technology.
Broad US patent granted to NeuroMEDx, covering its platform technology.